Lindsey Rolfe
2020
In 2020, Lindsey Rolfe earned a total compensation of $1.4M as EVP of Clinical Development and Pharmacovigilance and Chief Medical Officer at Clovis Oncology, a 48% decrease compared to previous year.
Compensation breakdown
| Bonus | $254,784 |
|---|---|
| Salary | $518,294 |
| Stock Awards | $613,460 |
| Total | $1,386,538 |
Rolfe received $613.5K in stock awards, accounting for 44% of the total pay in 2020.
Rolfe also received $254.8K in bonus and $518.3K in salary.
Rankings
In 2020, Lindsey Rolfe's compensation ranked 7,193rd out of 13,090 executives tracked by ExecPay. In other words, Rolfe earned more than 45.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,193 out of 13,090 | 45th |
Division Manufacturing | 3,006 out of 5,620 | 47th |
Major group Chemicals And Allied Products | 1,214 out of 2,253 | 46th |
Industry group Drugs | 1,047 out of 1,953 | 46th |
Industry Pharmaceutical Preparations | 781 out of 1,458 | 46th |
Pay ratio
| Lindsey Rolfe's Pay | $1,386,538 |
|---|---|
| Median Employee's Pay | $230,943 |
| Pay Ratio | 6to 1 |
In 2020, the annual total compensation of Lindsey Rolfe was $1,386,538.
The annual total compensation of the median employee at Clovis Oncology was $230,943.
The ratio of Lindsey Rolfe's pay to the pay of median employee was therefore 6 to one.
Source: SEC filing on April 28, 2021.
Rolfe's colleagues
We found four more compensation records of executives who worked with Lindsey Rolfe at Clovis Oncology in 2020.
News
Clovis Oncology CEO Patrick Mahaffy's 2021 pay slips 18% to $2.6M
April 27, 2022
Clovis Oncology CEO Patrick Mahaffy's 2020 pay falls 53% to $3.2M
April 28, 2021
Clovis Oncology CEO Patrick Mahaffy's 2019 pay rises 10% to $6.9M
April 24, 2020
Clovis Oncology CEO Patrick Mahaffy's 2018 pay falls 28% to $6.3M
April 26, 2019